Cargando...
Immune Checkpoint Inhibitors in Lung Cancer: Role of Biomarkers and Combination Therapies
Lung cancer is the leading cause of cancer-related death worldwide, with a poor prognosis. Despite aggressive treatment, progression-free survival (PFS) and overall survival are limited. Recently, various kinds of immune checkpoint inhibitors (ICIs) have emerged for several cancers, targeting PD1, P...
Gardado en:
| Publicado en: | Cureus |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Cureus
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7292688/ https://ncbi.nlm.nih.gov/pubmed/32542150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.8095 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|